[144/A] Freedom Holding Corp. SEC Filing

Rhea-AI Filing Summary

Form 144/A filed for Freedom Holding Corp. (FRHC) reports a proposed sale of 3,006 common shares on the Kazakhstan Stock Exchange (KASE) with an aggregate market value of 520,038. The filing lists total shares outstanding as 61,205,640 and an approximate sale date of 08/29/2025.

The securities table shows 3,000 shares were acquired on 05/18/2025 through vesting of an employee stock grant, paid as equity compensation. The filer reports no shares sold in the past three months and includes the standard representation that the seller is not aware of any undisclosed material adverse information about the issuer.

Insights

Financial Analyst

TL;DR: Routine insider sale notice for a small block of vested shares; no recent sales reported.

The filing documents a proposed sale of 3,006 common shares with an aggregate market value of 520,038 on KASE, and notes acquisition of 3,000 shares via vesting on 05/18/2025. There are no reported sales in the prior three months. From a capital-markets perspective, this appears to be a standard Rule 144 notification of an employee-originated disposition rather than a corporate financing or material disclosure. The filing includes the required representation about absence of undisclosed material adverse information.

Corporate Governance Expert

TL;DR: Compliance-focused disclosure of a planned insider sale tied to vested equity; procedural and non-disruptive.

The notice indicates the securities to be sold derive from equity compensation vesting and were acquired from the issuer on 05/18/2025. The form contains the standard attestations and no prior three-month sales, which supports routine compliance with Rule 144 requirements. There is no disclosure here of governance events, related-party transactions beyond the equity grant, or any material nonpublic information.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144/A

144/A: Filer Information

Filer CIK
Filer CCC
Previous Accession Number Of The Filing
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144/A: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144/A: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
COMMON	Freedom Finance Global PLC 16, Dostyk street, integral nonz-residen Talan Tower Offices Astana 1P 010017	3006	520038	61205640	08/29/2025	KASE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144/A: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock, par value $0.001 per share	05/18/2025	Vesting of employee stock grant	Issuer			3000	05/18/2025	Equity Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144/A: Securities Sold During The Past 3 Months

Nothing to Report

144/A: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What securities are being offered for sale in the FRHC 144/A filing?

The filing proposes sale of 3,006 common shares of Freedom Holding Corp. on KASE.

What is the aggregate market value and proposed sale date for the shares?

Aggregate market value is reported as 520,038 with an approximate sale date of 08/29/2025.

How and when were the shares being sold acquired according to the filing?

The filing states 3,000 shares were acquired on 05/18/2025 by vesting of an employee stock grant, paid as equity compensation.

Has the seller reported any sales of issuer securities in the past three months?

The filing reports Nothing to Report for securities sold during the past three months.

Does the filing include any representation about undisclosed material information?

Yes; the signer represents they do not know any material adverse information about the issuer that has not been publicly disclosed.